Loading
Latest filing published 05 Jun 2024 for Celldex Therapeutics, Inc., €52k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Margo Heath-Chiozzi, listed as senior executive, appears in our data through filings on Celldex Therapeutics, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 11 August 2021 and the latest from 3 June 2024.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 5 June 2024 with an option exercise (€52k) in Celldex Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations